Intestinal transport of deoxynivalenol across porcine small intestines

Archives of Animal Nutrition

Volumn 67, Issue 2, 2013, Pages 134-146

  Halawa, Amal ^a,c   Dänicke, Sven ^b   Kersten, Susanne ^b   Breves, Gerhard ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c Mansoura University   (Egypt)

Author keywords

deoxynivalenol; in vitro; lipopolysaccharides; mucosa; pigs; transport processes; tumour necrosis factor

Indexed keywords

LIPOPOLYSACCHARIDE; TRICHOTHECENE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VOMITOXIN;

ANIMAL; ANIMAL DISEASE; ANIMAL FOOD; ARTICLE; BLOOD; CHEMISTRY; DIET; MALE; METABOLISM; PHYSIOLOGY; SMALL INTESTINE; SWINE; TRANSPORT AT THE CELLULAR LEVEL; WEIGHT GAIN;

ANIMAL FEED; ANIMALS; BIOLOGICAL TRANSPORT; DIET; INTESTINE, SMALL; LIPOPOLYSACCHARIDES; MALE; SWINE; TRICHOTHECENES; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

ANIMALIA; NEGIBACTERIA; SUIDAE; SUS;

EID: 84875865390     PISSN: 1745039X     EISSN: 14772817     Source Type: Journal    
DOI: 10.1080/1745039X.2013.776327     Document Type: Article

References (54)

1. Abramović, B, Jajić, I, Jurić, V and Gaál, FF. 2005. Optimization of the determination of deoxynivalenol in corn samples by liquid chromatography and a comparison of two clean-up principles. J Serb Chem Soc, 70(7): 1005-1013.
2. Amuzie, CJ, Shinozuka, J and Pestka, JJ. 2009. Induction of suppressors of cytokine signalling by the trichothecene deoxynivalenol in the mouse. Toxicol Sci, 111(2): 277-287.
3. Avantaggiato, G, Havenaar, R and Visconti, A. 2004. Evaluation of the intestinal absorption of deoxynivalenol and nivalenol by an in vitro gastrointestinal model, and the binding efficacy of activated carbon and other adsorbent materials. Food Chem Toxicol, 42: 817-824.
4. Awad, WA, Aschenbach, JR, Setyabudi, FMCS, Razzazi-Fazeli, E, Böhm, J and Zentek, J. 2007. In vitro effects of deoxynivalenol on small intestinal D-glucose uptake and absorption of deoxynivalenol across the isolated jejunal epithelium of laying hens. Poult Sci, 86: 15-20.
5. Binder, EM, Tan, LM, Chin, LJ, Handl, J and Richard, J. 2007. Worldwide occurrence of mycotoxins in commodities, feeds and feed ingredients. Anim Feed Sci Technol, 137: 265-282.
6. Cheng, Y, Weng, C, Chen, B and Chang, M. 2006. Toxicity of different Fusarium mycotoxins on growth performance, immune responses and efficacy of a mycotoxin degrading enzyme in pigs. Anim Res, 55: 579-590.
7. Chung, Y-J, Zhou, H-R and Pestka, JJ. 2003. Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-α expression by deoxynivalenol (Vomitoxin). Toxicol Appl Pharmacol, 193: 188-201.
8. Cui, W, Li, LX, Sun, CM, Wen, Y, Zhou, Y, Dong, YL and Liu, P. 2010. Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells. Braz J Med Biol Res, 43: 330-337.
9. Dänicke, S, Brüssow, K-P, Valenta, H, Ueberschär, K-H, Tiemann, U and Schollenberger, M. 2005. On the effects of graded levels of Fusarium toxin contaminated wheat in diets for gilts on feed intake, growth performance and metabolism of deoxynivalenol and zearalenone. Mol Nutr Food Res, 49: 932-943.
10. Dänicke, S, Döll, S, Goyarts, T, Seeling, K, Valenta, H and Ueberschär, K-H. 2008. "Metabolism, kinetics and occurrence of deoxynivalenol (DON) and zearalenone (ZON) in physiological samples of pigs, ruminants and poultry". In Mycotoxins in farm animals, Edited by: Oswald, IP and Taranu, I. 235-273. Trivandrum: Transworld Research Network. editors
11. Dänicke, S, Valenta, H and Döll, S. 2004. On the toxicokinetics and the metabolism of deoxynivalenol (DON) in the pig. Arch Anim Nutr, 58(2): 169-180.
12. Dänicke, S, Valenta, H, Klobasa, F, Döll, S, Ganter, M and Flachowsky, G. 2004. Effects of graded levels of Fusarium toxin contaminated wheat in diets for fattening pigs on growth performance, nutrient digestibility, deoxynivalenol balance and clinical serum characteristics. Arch Anim Nutr, 58(1): 1-17.
13. Döll, S and Dänicke, S. 2011. The Fusarium toxins deoxynivalenol (DON) and zearalenone (ZON) in animal feeding. Prev Vet Med, 102(2): 132-145.
14. Döll, S, Schrickx, JA, Dänicke, S and Fink-Gremmels, J. 2009. Deoxynivalenol-induced cytotoxicity, cytokines and related genes in unstimulated or lipopolysaccharide stimulated primary porcine macrophages. Toxicol Lett, 184: 97-106.
15. Döll, S, Schrickx, JA, Valenta, H, Dänicke, S and Fink-Gremmels, J. 2009. Interactions of deoxynivalenol and lipopolysaccharides on cytotoxicity protein synthesis and metabolism of DON in porcine hepatocytes and Kupffer cell enriched hepatocyte cultures. Toxicol Lett, 189(2): 121-129.
16. Drewe, J, Beglinger, C and Fricker, G. 2001. Effect of ischemia on intestinal permeability of lipopoly- saccharides. Eur J Clin Invest, 31: 138-144.
17. EFSA. 2004. Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to deoxynivalenol (DON) as undesirable substance in animal feed. EFSA J, 73: 1-41.
18. Eriksen, GS and Pettersson, H. 2004. Toxicological evaluation of trichothecenes in animal feed. Anim Feed Sci Technol, 114(1): 205-239.
19. Eriksen, GS, Pettersson, H and Lindberg, JE. 2003. Absorption, metabolism and excretion of 3-acetyl DON in pigs. Arch Anim Nutr, 57(5): 335-345.
20. European Food Safety Authority. 2004. Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to deoxynivalenol (DON) as undesirable substance in animal feed. EFSA J, 73: 1-41.
21. Goyarts, T and Dänicke, S. 2006. Bioavailability of the Fusarium toxin deoxynivalenol (DON) from naturally contaminated wheat for the pig. Toxicol Lett, 163(3): 171-182.
22. Halawa, A, Dänicke, S, Kersten, S and Breves, G. 2012. Effects of deoxynivalenol and lipopolysaccharide on electrophysiological parameters in growing pigs. Mycotox Res, 28(4): 243-252.
23. 13C isotope labelled internal standard for the determination of the mycotoxin Deoxynivalenol by LC-MS/MS without clean up. Anal Bioanal Chem, 384(3): 692-696.
24. He, J, Li, X-Z and Zhou, T. 2009. Sample clean-up methods, immunoaffinity chromatography and solid phase extraction, for determination of deoxynivalenol and deepoxy deoxynivalenol in swine serum. Mycotoxin Res, 25(2): 89-94.
25. Hewett, JA and Roth, RA. 1993. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev, 45(4): 381-411.
26. Hussein, HE and Brasel, JM. 2001. Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology, 167(2): 101-134.
27. Islam, Z and Pestka, JJ. 2006. LPS priming potentiates and prolongs proinflammatory cytokine response to the trichothecene deoxynivalenol in the mouse. Toxicol Appl Pharmacol, 211(1): 53-63.
28. Kadota, T, Takezawa, Y, Hirano, S, Tajima, O, Maragos, C, Nakajima, T, Tanaka, T, Kamata, Y and Sugita-Konishi, Y. 2010. Rapid detection of nivalenol and deoxynivalenol in wheah using surface plasmon resonance immunoassay. Anal Chim Acta, 673(2): 173-178.
29. Kimura, H, Sawada, N, Tobioka, H, Isomura, H, Kokai, Y, Hirata, K and Mori, M. 1997. Bacterial lipopolysaccharide reduced intestinal barrier function and altered localization of 7H6 antigen in IEC-6 rat intestinal crypt cells. J Cell Physiol, 171(3): 284-290.
30. Kollarczik, B, Gareis, M and Hanelt, M. 1994. In vitro transformation of the Fusarium mycotoxins deoxynivalenol and zearalenone by the normal gut microflora of pigs. Natural Toxins, 2(3): 105-110.
31. Königs, M, Lenczyk, M, Schwerdt, G, Holzinger, H, Gekle, M and Humpf, H-U. 2007. Cytotoxicity, metabolism and cellular uptake of the mycotoxin deoxynivalenol in human proximal tubule cells and lung fibroblasts in primary culture. Toxicology, 240(1-2): 48-59.
32. Krska, R and Molinelli, A. 2007. Mycotoxin analysis: state-of-the-art and future trends. Anal Bioanal Chem, 387(1): 145-148.
33. Larsen, JC, Hunt, J, Perrin, I and Ruckenbauer, P. 2004. Workshop on trichothecenes with a focus on DON: summary report. Toxicol Lett, 153(1): 1-22.
34. Ma, TY, Iwamoto, GK, Hoa, NT, Akotia, V, Pedram, A, Boivin, MA and Said, HM. 2004. TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-k{cyrillic}B activation. Am J Physiol Gastrointest Liver Physiol, 286(3): G367-G376.
35. Maresca, M, Mahfoud, R, Garmy, N and Fantini, J. 2002. The mycotoxin deoxynivalenol affects nutrient absorption in human intestinal epithelial cells. J Nutr, 132(9): 2723-2731.
36. Matthäus, K, Dänicke, S, Vahjen, W, Simon, O, Wang, J, Valenta, H, Meyer, K, Strumpf, A, Zieseniß, H and Flachowsky, G. 2004. Progression of mycotoxin and nutrient concentrations in wheat after inoculation with Fusarium culmorum. Arch Anim Nutr, 58(1): 19-35.
37. Naumann, C and Bassler, R. 1993. Die chemische Untersuchung von Futtermitteln. Darmstadt: VDLUFA-Verlag,
38. Norimatsu, M, Ono, T, Aoki, A, Takahashi, T, Watanabe, G, Taya, K, Sasamoto, S and Tamura, Y. 1995. Lipopolysaccharide-induced apoptosis in swine lymphocytes in vivo. Infect Immun, 63(3): 1122-1126.
39. Oldenburg, E, Bramm, A and Valenta, H. 2007. Influence of nitrogen fertilization on deoxynivalenol contamination of winter wheat-experimental field trials and evaluation of analytical methods. Mycotox Res, 23(1):7-12.
40. Pestka, JJ, Zhou, H-R, Moon, Y and Chung, YJ. 2004. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unravelling a paradox. Toxicol Lett, 153(1): 61-73.
41. Pinton, P, Braicu, C, Nougayrede, JP, Laffitte, J, Taranu, I and Oswald, IP. 2010. Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependant mechanism. J Nutr, 140(11): 1956-1962.
42. Prelusky, DB. 1997. Effect of intraperitoneal infusion of deoxynivalenol on feed consumption and weight gain in the pig. Nat Toxins, 5(3): 121-125.
43. Prelusky, DB, Hamilton, RMG, Trenholm, HL and Miller, JD. 1986. Tissue distribution and excretion of radioactivity following administration of 14C-labeled deoxynivalenol to White Leghorn hens. Fundam Appl Toxicol, 7(4): 635-645.
44. 14C-labeled deoxynivalenol in swine. Fundam Appl Toxicol, 10(2): 276-286.
45. Prelusky, DB and Trenholm, HL. 1991. Tissue distribution of deoxynivalenol in swine dosed intravenously. J Agric Food Chem, 39(4): 748-751.
46. Prelusky, DB and Trenholm, HL. 1992. Nonaccumulation of residues in swine tissue following extended consumption of deoxynivalenol-contaminated diets. J Food Sci, 57(4): 801-802.
47. Schothorst, RC and Egmond, HP. 2004. Report from SCOOP task 3.2.10 "collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states". Subtask: trichothecenes. Toxicol Lett, 153(1): 133-143.
48. Sergent, T, Parys, M, Garsou, S, Pusseemier, L, Schneider, Y and Larondelle, Y. 2006. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicol Lett, 164(2): 167-176.
49. Turner, JR. 2009. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol, 9(11): 799-809.
50. Valenta, H, Dänicke, S and Döll, S. 2003. Analysis of deoxynivalenol and de-epoxy-deoxynivalenol in animal tissues by liquid chromatography after clean-up with an immunoaffinity column. Mycotox Res, 19(1): 51-55.
51. Videmann, B, Tep, J, Cavret, S and Lecoeur, S. 2007. Epithelial transport of deoxynivalenol: involvement of human P-glycoprotein (ABCB1) and multidrug resistance-associated protein 2 (ABCC2). Food Chem Toxicol, 45(10): 1938-1947.
52. Webel, DM, Fink, BN, Baker, DH and Johnson, RW. 1997. Time course of increased plasma cytokines, cortisol, and urea nitrogen in pigs following intraperitoneal injection of lipopolysaccharide. JAnim Sci, 75(6): 1514-1520.
53. Wright, KJ, Balaji, R, Hill, CM, Dritz, SS, Knoppel, EL and Minton, JE. 2000. Integrated adrenal, somatotropic, and immune responses of growing pigs to treatment with lipopolysaccharide. JAnim Sci, 78(7): 1892-1899.
54. Yu, LCH, Flynn, AN, Turner, JR and Buret, AG. 2005. SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism?. FASEB J, 19(13): 1822-1835.